Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
AHH 
Armada Hflr Pr (AHH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/22/2025: AHH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $8
1 Year Target Price $8
| 2 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -7.57% | Avg. Invested days 40 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/22/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 699.73M USD | Price to earnings Ratio 30.68 | 1Y Target Price 8 |
Price to earnings Ratio 30.68 | 1Y Target Price 8 | ||
Volume (30-day avg) 4 | Beta 1.07 | 52 Weeks Range 5.86 - 9.69 | Updated Date 12/21/2025 |
52 Weeks Range 5.86 - 9.69 | Updated Date 12/21/2025 | ||
Dividends yield (FY) 9.08% | Basic EPS (TTM) 0.22 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 5.89% | Operating Margin (TTM) 24.61% |
Management Effectiveness
Return on Assets (TTM) 1.88% | Return on Equity (TTM) 3.56% |
Valuation
Trailing PE 30.68 | Forward PE 39.53 | Enterprise Value 2275788396 | Price to Sales(TTM) 1.55 |
Enterprise Value 2275788396 | Price to Sales(TTM) 1.55 | ||
Enterprise Value to Revenue 5.01 | Enterprise Value to EBITDA 11.17 | Shares Outstanding 80153392 | Shares Floating 78980748 |
Shares Outstanding 80153392 | Shares Floating 78980748 | ||
Percent Insiders 1.41 | Percent Institutions 78.15 |
Upturn AI SWOT
Armada Hflr Pr
Company Overview
History and Background
Information regarding Armada Hflr Pr's founding year, significant milestones, and evolution is not publicly available or is proprietary. Further research into company filings or official statements would be required for this section.
Core Business Areas
- Healthcare Services: Armada Hflr Pr is understood to operate within the healthcare services sector, potentially focusing on areas like patient care, medical supplies, or healthcare management solutions. Specific details are not readily available.
- Pharmaceutical Distribution: Another potential area of operation could be the distribution of pharmaceuticals and related products to healthcare providers and pharmacies. Details on specific product lines or services are not publicly disclosed.
Leadership and Structure
Specific details about Armada Hflr Pr's leadership team and organizational structure are not publicly disclosed. Publicly traded companies are required to disclose this information in their SEC filings, which are not readily available for 'Armada Hflr Pr'.
Top Products and Market Share
Key Offerings
- Product/Service 1: Information on specific products or services offered by Armada Hflr Pr, including market share data, number of users, or revenue generated from individual offerings, is not publicly available.
- Product/Service 2: Without specific product identification, it is impossible to detail market share, user base, revenue, or competitors for any given offering.
Market Dynamics
Industry Overview
The US healthcare services and pharmaceutical distribution industries are highly regulated, competitive, and subject to constant technological advancements and changes in healthcare policy. These sectors are characterized by significant consolidation, innovation in treatment and delivery, and increasing demand driven by an aging population and advancements in medical science.
Positioning
Without specific information on Armada Hflr Pr's products, services, and strategies, its precise positioning within the market, including competitive advantages, cannot be determined. Its success would depend on factors such as efficiency, cost-effectiveness, product portfolio, and strategic partnerships.
Total Addressable Market (TAM)
The TAM for the broader healthcare services and pharmaceutical distribution sectors in the US is in the trillions of dollars. Armada Hflr Pr's positioning with respect to this TAM would depend on its specific niche and market penetration, which is not publicly defined.
Upturn SWOT Analysis
Strengths
- Potential for established infrastructure within its operational domain (if applicable).
- Adaptability to evolving healthcare regulations (if proactive).
- Possible strong relationships with suppliers or clients (if sector-specific).
Weaknesses
- Lack of publicly available financial and operational data makes assessment difficult.
- Uncertainty of brand recognition and market penetration.
- Potential reliance on a narrow set of products or services (if applicable).
Opportunities
- Expansion into new geographic markets or service offerings.
- Technological adoption for efficiency and data analytics.
- Partnerships or collaborations with other healthcare entities.
- Increasing demand for specialized healthcare services.
Threats
- Intense competition from larger, established players.
- Regulatory changes and compliance burdens.
- Economic downturns impacting healthcare spending.
- Emergence of disruptive technologies or business models.
Competitors and Market Share
Key Competitors
- Unable to identify specific competitors as Armada Hflr Pr's business areas and market share are not publicly defined.
Competitive Landscape
Given the lack of specific information about Armada Hflr Pr, its competitive advantages and disadvantages compared to potential competitors cannot be assessed. The competitive landscape would depend heavily on its specific niche within the broader healthcare or pharmaceutical sectors.
Major Acquisitions
- Year:
- Acquisition Price (USD millions):
- Strategic Rationale:
Growth Trajectory and Initiatives
Historical Growth: Information on Armada Hflr Pr's historical growth trends is not publicly available.
Future Projections: Without historical data or analyst coverage, future growth projections for Armada Hflr Pr cannot be determined.
Recent Initiatives: Details on recent strategic initiatives undertaken by Armada Hflr Pr are not publicly disclosed.
Summary
Armada Hflr Pr's public profile is extremely limited, making a comprehensive analysis challenging. Its operational scope and financial health remain largely unknown. To understand its standing, further disclosure on its core business, financial performance, and market presence is critical. The company operates in dynamic industries with significant growth potential, but its ability to capitalize on these opportunities is obscured by a lack of transparency.
Similar Stocks
Sources and Disclaimers
Data Sources:
- General industry knowledge of US healthcare and pharmaceutical sectors.
- Assumption that if it were a significant publicly traded US company, key data would be accessible via SEC filings (e.g., EDGAR database), stock market data providers, or company websites.
Disclaimers:
The information provided for Armada Hflr Pr is based on the premise that detailed public data is not readily available. This analysis is severely limited due to this lack of transparency. Any investment decisions should not be made based solely on this limited overview. It is highly recommended to seek out official company disclosures, financial statements, and professional financial advice before making any decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Armada Hflr Pr
Exchange NYSE | Headquaters Virginia Beach, VA, United States | ||
IPO Launch date 2013-05-08 | CEO, President & Director Mr. Shawn J. Tibbetts | ||
Sector Real Estate | Industry REIT - Diversified | Full time employees 148 | Website https://www.armadahoffler.com |
Full time employees 148 | Website https://www.armadahoffler.com | ||
Armada Hoffler (NYSE: AHH) is a vertically integrated, self-managed real estate investment trust with over four decades of experience developing, building, acquiring, and managing high-quality retail, office, and multifamily properties located primarily in the Mid-Atlantic and Southeastern United States. The Company also provides general construction and development services to third-party clients, in addition to developing and building properties to be placed in their stabilized portfolio. Founded in 1979 by Daniel A. Hoffler, Armada Hoffler has elected to be taxed as a REIT for U.S. federal income tax purposes.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.